New asthma drug shows promise in Real-World spanish study

NCT ID NCT06487065

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 33 times

Summary

This study looked at 33 people with severe asthma who received tezepelumab before it was widely available in Spain. Researchers checked how well the drug controlled asthma symptoms and tracked side effects. The goal was to see how the drug works outside of a clinical trial setting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Alcázar de San Juan, Spain

  • Research Site

    Almería, Spain

  • Research Site

    Badajoz, Spain

  • Research Site

    Bilbao, Spain

  • Research Site

    Coslada, Spain

  • Research Site

    Donostia / San Sebastian, Spain

  • Research Site

    Fuenlabrada, Spain

  • Research Site

    Gran Canaria, Spain

  • Research Site

    Lugo, Spain

  • Research Site

    Madrid, Spain

  • Research Site

    Málaga, Spain

  • Research Site

    Talavera de la Reina, Spain

  • Research Site

    Torrejón de Ardoz, Spain

  • Research Site

    Valencia, Spain

Conditions

Explore the condition pages connected to this study.